UniProt ID | BDH2_HUMAN | |
---|---|---|
UniProt AC | Q9BUT1 | |
Protein Name | 3-hydroxybutyrate dehydrogenase type 2 | |
Gene Name | BDH2 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 245 | |
Subcellular Localization | Cytoplasm . | |
Protein Description | Dehydrogenase that mediates the formation of 2,5-dihydroxybenzoic acid (2,5-DHBA), a siderophore that shares structural similarities with bacterial enterobactin and associates with LCN2, thereby playing a key role in iron homeostasis and transport. Also acts as a 3-hydroxybutyrate dehydrogenase (By similarity).. | |
Protein Sequence | MGRLDGKVIILTAAAQGIGQAAALAFAREGAKVIATDINESKLQELEKYPGIQTRVLDVTKKKQIDQFANEVERLDVLFNVAGFVHHGTVLDCEEKDWDFSMNLNVRSMYLMIKAFLPKMLAQKSGNIINMSSVASSVKGVVNRCVYSTTKAAVIGLTKSVAADFIQQGIRCNCVCPGTVDTPSLQERIQARGNPEEARNDFLKRQKTGRFATAEEIAMLCVYLASDESAYVTGNPVIIDGGWSL | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
32 | Ubiquitination | AFAREGAKVIATDIN HHHHCCCEEEEEECC | 45.06 | 30230243 | |
41 | Phosphorylation | IATDINESKLQELEK EEEECCHHHHHHHHH | 33.89 | 28857561 | |
42 | Ubiquitination | ATDINESKLQELEKY EEECCHHHHHHHHHC | 48.27 | 23000965 | |
42 | Sumoylation | ATDINESKLQELEKY EEECCHHHHHHHHHC | 48.27 | - | |
48 | Acetylation | SKLQELEKYPGIQTR HHHHHHHHCCCCCEE | 70.17 | 19608861 | |
48 (in isoform 2) | Ubiquitination | - | 70.17 | 21890473 | |
48 (in isoform 1) | Ubiquitination | - | 70.17 | 21890473 | |
48 | Ubiquitination | SKLQELEKYPGIQTR HHHHHHHHCCCCCEE | 70.17 | 21890473 | |
48 | Ubiquitination | SKLQELEKYPGIQTR HHHHHHHHCCCCCEE | 70.17 | 21890473 | |
48 | Ubiquitination | SKLQELEKYPGIQTR HHHHHHHHCCCCCEE | 70.17 | 23000965 | |
61 | Acetylation | TRVLDVTKKKQIDQF EEEEECCCHHHHHHH | 58.80 | 25953088 | |
61 | 2-Hydroxyisobutyrylation | TRVLDVTKKKQIDQF EEEEECCCHHHHHHH | 58.80 | - | |
62 | Ubiquitination | RVLDVTKKKQIDQFA EEEECCCHHHHHHHH | 40.31 | 29967540 | |
63 | Ubiquitination | VLDVTKKKQIDQFAN EEECCCHHHHHHHHH | 54.78 | 24816145 | |
63 | Acetylation | VLDVTKKKQIDQFAN EEECCCHHHHHHHHH | 54.78 | 23954790 | |
101 | Phosphorylation | EEKDWDFSMNLNVRS CCCCCCCCCCCCHHH | 12.32 | 29116813 | |
124 | Ubiquitination | LPKMLAQKSGNIINM HHHHHHHHCCCEEEH | 55.51 | 29967540 | |
124 | Acetylation | LPKMLAQKSGNIINM HHHHHHHHCCCEEEH | 55.51 | 7675547 | |
125 | Phosphorylation | PKMLAQKSGNIINMS HHHHHHHCCCEEEHH | 25.62 | 21406692 | |
132 | Phosphorylation | SGNIINMSSVASSVK CCCEEEHHHHHHHHH | 19.71 | 21406692 | |
133 | Phosphorylation | GNIINMSSVASSVKG CCEEEHHHHHHHHHH | 15.78 | 21406692 | |
136 | Phosphorylation | INMSSVASSVKGVVN EEHHHHHHHHHHHHH | 33.24 | 21406692 | |
137 | Phosphorylation | NMSSVASSVKGVVNR EHHHHHHHHHHHHHH | 20.36 | 21406692 | |
139 | Acetylation | SSVASSVKGVVNRCV HHHHHHHHHHHHHHH | 48.19 | 7675557 | |
139 | Ubiquitination | SSVASSVKGVVNRCV HHHHHHHHHHHHHHH | 48.19 | 32015554 | |
151 | Acetylation | RCVYSTTKAAVIGLT HHHHHHHHHHHHHCC | 34.14 | 88291 | |
159 (in isoform 1) | Ubiquitination | - | 48.23 | 21890473 | |
159 | Ubiquitination | AAVIGLTKSVAADFI HHHHHCCHHHHHHHH | 48.23 | 21890473 | |
159 | Ubiquitination | AAVIGLTKSVAADFI HHHHHCCHHHHHHHH | 48.23 | 21890473 | |
159 | Ubiquitination | AAVIGLTKSVAADFI HHHHHCCHHHHHHHH | 48.23 | 22053931 | |
166 | Ubiquitination | KSVAADFIQQGIRCN HHHHHHHHHCCCCCC | 2.84 | 27667366 | |
173 | Ubiquitination | IQQGIRCNCVCPGTV HHCCCCCCEECCCCC | 16.06 | 21890473 | |
182 | Phosphorylation | VCPGTVDTPSLQERI ECCCCCCCHHHHHHH | 15.50 | 28857561 | |
184 | Phosphorylation | PGTVDTPSLQERIQA CCCCCCHHHHHHHHH | 44.79 | 28857561 | |
204 | Ubiquitination | EARNDFLKRQKTGRF HHHHHHHHHHHCCCC | 53.42 | 27667366 | |
218 | Ubiquitination | FATAEEIAMLCVYLA CCCHHHHHHHHHHHH | 6.54 | 27667366 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of BDH2_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of BDH2_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of BDH2_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
BDH2_HUMAN | BDH2 | physical | 25416956 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-48, AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Automated phosphoproteome analysis for cultured cancer cells by two-dimensional nanoLC-MS using a calcined titania/C18 biphasic column."; Imami K., Sugiyama N., Kyono Y., Tomita M., Ishihama Y.; Anal. Sci. 24:161-166(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-132, AND MASSSPECTROMETRY. |